Search
Menu
Home
HTB
2021
March
HTB
March 2021
Contents
Editorial
HTB: no. 3 – plus HIV and COVID-19 (12 March 2021)
In memory
In memory: Dr Charles Boucher – leading HIV doctor, researcher and educator
Conference reports
28th Conference on Retroviruses and Opportunistic Infections (CROI 2021)
CROI 2021: Urgency of global access to vaccines, the potential of mAbs and the lessons learned from HIV
CROI 2021: Community challenge 6-month CROI pay wall – rather than usual open access…
CROI 2021: Once-daily GSK254 maturation inhibitor as treatment for HIV multidrug resistance
CROI 2021: Dosing for once-weekly oral ART: islatravir plus MK-8507 studies due to start in 2021
CROI 2021: Islatravir dosing for once-monthly and annual PrEP: if effective this could end HIV transmission
CROI 2021: Dolutegravir with recycled tenofovir and lamivudine performs well second-line: primary results from the NADIA trial
CROI 2021: HIV capsid uncoats in the CD4 nucleus rather than the cytoplasm – viral lifecycle updated…
CROI 2021: Community HIV cure workshops online
Side effects
Chronic kidney disease (CKD) in HIV positive people linked to time with low CD4 count: partly reversible after effective ART
Research studies
Switch study for people with insomnia using dolutegravir
COVID-19: vaccine research
Janssen/J&J vaccine against COVID-19 is approved in the EU
COVID-19: investigational drugs
Baricitinib improves recovery in sub-group of adults hospitalised COVID-19: results from ACTT-2 study
Ivermectin has no impact in treating mild COVID-19 in 400 adults in Columbia
No benefit from BRII and GSK monoclonal antibodies against COVID-19 in ACTIV-3 study
PDFs
HTB: no.3 – plus HIV and COVID-19 (12 March 2021)
HTB RSS
Current issues
October 2024
September 2024
August 2024
Back issues
Special report
HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care
6 October 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage